The Absence of Blood Oxygen Sensing

When Apple unveiled its highly anticipated Apple Watch models on September 9, a notable feature was conspicuously absent in the U.S. market—the blood oxygen sensing capability, which has been a staple of Apple Watches since the Series 6 launch in 2020 (excluding the Watch SE models). This crucial health feature has been sidelined for nearly a year due to a protracted patent dispute with medical device company Masimo. However, new developments suggest that it may soon return.

Potential Changes in Negotiations

Recent news indicates a pivotal shift, as Joe Kiani, the long-standing CEO of Masimo, has recently stepped down. This unexpected change might pave the way for negotiations between Apple and Masimo to potentially reinstate the blood oxygen monitoring feature in upcoming Apple Watch models, as highlighted in Bloomberg’s Mark Gurman’s latest Power On newsletter.

Consumer Implications

For many consumers, this is promising news. If you purchased the Apple Watch Ultra 2 upon its September release, it originally came with the blood oxygen feature. However, those who opted for the sleek black version had to forgo this essential health tool since it has been disabled on all models equipped with the sensor since last January.

Geographical Limitations

It's important to note that this restriction currently only affects Apple Watches sold in the U.S. For instance, my Series 10, which was obtained from the U.K., continues to utilize the sensor without issue.

Future Prospects

While uncertainties remain regarding whether this leadership change will facilitate a resolution, the prospect of Kiani's exit may offer both companies an opportunity to realign their strategies. Gurman speculates that Apple might not necessarily pursue a licensing agreement but could explore an alternative deal that would allow both companies to halt ongoing legal disputes.

Restoration of Features

As it stands, the blood oxygen sensors are still integrated into the existing models, including the Series 9 and Ultra 2, which were rendered inactive after the legal spat. Should Apple and Masimo reach an agreement, these features could be restored.

Opportunities for Collaboration

Moreover, this development could open up further opportunities for collaboration, particularly with integrating Masimo’s acclaimed hospital technology into Apple’s Health app.

Personal Outlook

As a frequent user of the blood oxygen sensing feature, I eagerly anticipate its return. The health benefits of continuous monitoring are undeniable, and restoring this feature would certainly enhance the overall value of the Apple Watch experience for many users. Stay tuned for updates on this evolving story!